Tirzepatide vs Retatrutide
How do Tirzepatide and Retatrutide compare for GLP-1 & Weight research? Side-by-side evidence, molecular profile, EU legal status and COA-verified supplier prices — never dosing advice.
At a glance
Tirzepatide
Retatrutide
Which fits which research target?
Both Tirzepatide and Retatrutide sit within GLP-1 & Weight research but are studied for different primary signals. Neither is an approved medicine — compare the evidence, not marketing claims.
What the research shows
Tirzepatide
Retatrutide
Compare prices across EU suppliers
Compare Tirzepatide across EU suppliers
7 EU vendors · COA · from €37.9
Compare Retatrutide across EU suppliers
15 EU vendors · COA · from €44.49
Frequently asked questions
Is Tirzepatide or Retatrutide better? ▾
Neither is an approved medicine, and “better” depends on the research target. Tirzepatide is most associated with Weight reduction, while Retatrutide is studied for Weight reduction. Compare the evidence tiers and COA-verified EU pricing above rather than assuming one is superior. This is not a usage recommendation.
Why compare Tirzepatide and Retatrutide? ▾
Both are studied within GLP-1 & Weight research through different mechanisms, so researchers often weigh them against each other. This page sets their evidence, molecular profile, EU legal status and supplier pricing side by side.
Which is cheaper in the EU, Tirzepatide or Retatrutide? ▾
Prices vary by supplier, vial size and COA status. Tirzepatide is listed from €37.9 across 7 COA-verified EU vendors; Retatrutide from €44.49 across 15. Open the price pages above to compare current listings — nobody pays us for placement.